Accurate dosimetry for monitoring response to photodynamic therapy

Photodynamic therapy (PDT) is becoming a treatment of choice for cancer because of its low cost, high effectiveness and low damage to healthy tissue. Successful PDT outcome depends on accurate dosimetry, which is currently lacking, leading to variable and/or ineffective treatment outcome. We report on our research and developmental efforts towards an implicit dosimetric method for PDT that will provide an accurate assessment of treatment effectiveness by continuous monitoring of the in vivo drug concentration and the oxygen concentration in tissue. This approach uses the same tools presently available for PDT, making it attractive to the health professionals without increasing treatment cost.

[1]  T J Dougherty,et al.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.

[2]  B. Eisenberg,et al.  Incidence of Gross and Microscopic Carcinoma in Specimens from Patients with Breast Cancer After Re‐Excision Lumpectomy , 1993, Annals of surgery.

[3]  E. Rosato,et al.  Factors associated with a positive reexcision after excisional biopsy for invasive breast cancer. , 1995, Surgery.

[4]  R. Poulson The enzymic conversion of protoporphyrinogen IX to protoporphyrin IX in mammalian mitochondria. , 1976, The Journal of biological chemistry.

[5]  A. Batlle,et al.  Aminolevulinic acid: from its unique biological function to its star role in photodynamic therapy. , 2005, The international journal of biochemistry & cell biology.

[6]  J. Hill,et al.  A history of photodynamic therapy. , 1991, The Australian and New Zealand journal of surgery.

[7]  Sergei A Vinogradov,et al.  Oxyphor R2 and G2: phosphors for measuring oxygen by oxygen-dependent quenching of phosphorescence. , 2002, Analytical biochemistry.

[8]  Can Ince,et al.  Mitochondrial PO2 measured by delayed fluorescence of endogenous protoporphyrin IX , 2006, Nature Methods.

[9]  H. Pass,et al.  Photodynamic therapy in oncology: mechanisms and clinical use. , 1993, Journal of the National Cancer Institute.

[10]  T J Dougherty,et al.  Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. , 1975, Journal of the National Cancer Institute.

[11]  C. Sibata,et al.  Breast Cancer With Chest Wall Progression: Treatment With Photodynamic Therapy , 2004, Annals of Surgical Oncology.

[12]  Michael S Patterson,et al.  Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro , 2005, Physics in medicine and biology.

[13]  W. Star,et al.  Light dosimetry in vivo. , 1997, Physics in medicine and biology.